{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:53:22Z","timestamp":1788324802912,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,3,9]],"date-time":"2006-03-09T00:00:00Z","timestamp":1141862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00381-006-1280-3","type":"journal-article","created":{"date-parts":[[2006,3,8]],"date-time":"2006-03-08T15:35:04Z","timestamp":1141832104000},"page":"334-337","source":"Crossref","is-referenced-by-count":61,"title":["Hydrocephalus in CINCA syndrome treated with anakinra"],"prefix":"10.1007","volume":"22","author":[{"given":"D.","family":"Rigante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ansuini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Caldarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"La Torraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,9]]},"reference":[{"key":"1280_CR1","first-page":"103","volume":"19","author":"AM Prieur","year":"2001","unstructured":"Prieur AM (2001) A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol 19:103\u2013106","journal-title":"Clin Exp Rheumatol"},{"key":"1280_CR2","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/art.10688","volume":"46","author":"I Aksentijevich","year":"2002","unstructured":"Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, Stein L, Russo R, Goldsmith D, Dent P, Rosenberg HF, Austin F, Remmers EF, Balow JE Jr, Rosenzweig S, Komarow H, Shoham NG, Wood G, Jones J, Mangra N, Carrero H, Adams BS, Moore TL, Schikler K, Hoffman H, Lovell DJ, Lipnick R, Barron K, O\u2019Shea JJ, Kastner DL, Goldbach-Mansky R (2002) De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 46:3340\u20133348","journal-title":"Arthritis Rheum"},{"key":"1280_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/03009748709102523","volume":"66","author":"AM Prieur","year":"1987","unstructured":"Prieur AM, Griscelli C, Lampert F, Truckenbrodt H, Guggenheim MA, Lovell DJ, Pelkonnen P, Chevrant-Breton J, Ansell BM (1987) A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analyzed in 30 patients. Scand J Rheumatol 66:57\u201368","journal-title":"Scand J Rheumatol"},{"key":"1280_CR4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000085086","volume":"20","author":"I Goldstein","year":"2005","unstructured":"Goldstein I, Copel JA, Makhoul IR (2005) Mild cerebral ventriculomegaly in fetuses: characteristics and outcome. Fetal Diagn Ther 20:281\u2013284","journal-title":"Fetal Diagn Ther"},{"key":"1280_CR5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/341357","volume":"71","author":"J Feldmann","year":"2002","unstructured":"Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, Cortis E, Teillac-Hamel D, Fischer A, de Saint Basile G (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71:198\u2013203","journal-title":"Am J Hum Genet"},{"key":"1280_CR6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1084\/jem.20050640","volume":"201","author":"CA Dinarello","year":"2005","unstructured":"Dinarello CA (2005) Blocking IL-1 in systemic inflammation. J Exp Med 201:1355\u20131359","journal-title":"J Exp Med"},{"key":"1280_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00063030-200519030-00005","volume":"19","author":"J Waugh","year":"2005","unstructured":"Waugh J, Perry CM (2005) Anakinra: a review of its use in the management of rheumatoid arthritis. BioDrugs 19:189\u2013202","journal-title":"BioDrugs"},{"key":"1280_CR8","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.clinthera.2004.12.019","volume":"26","author":"DE Furst","year":"2004","unstructured":"Furst DE (2004) Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther 26:1960\u20131975","journal-title":"Clin Ther"},{"key":"1280_CR9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/keh547","volume":"44","author":"B Granel","year":"2005","unstructured":"Granel B, Serratrice J, Disdier P, Weiller P-J (2005) Dramatic improvement with anakinra in a case of chronic infantile neurological cutaneous and articular (CINCA) syndrome. Rheumatology 44:689\u2013690","journal-title":"Rheumatology"},{"key":"1280_CR10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.20953","volume":"52","author":"DJ Lovell","year":"2005","unstructured":"Lovell DJ, Bowyer SL, Solinger AM (2005) Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease. Arthritis Rheum 52:1283\u20131286","journal-title":"Arthritis Rheum"},{"key":"1280_CR11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S1471-4914(02)02425-5","volume":"8","author":"M McDermott","year":"2002","unstructured":"McDermott M (2002) Genetic clues to understanding periodic fevers and possible therapies. Trends Mol Med 8:550\u2013554","journal-title":"Trends Mol Med"},{"key":"1280_CR12","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.neuroimage.2005.05.035","volume":"27","author":"S Papiol","year":"2005","unstructured":"Papiol S, Molina V, Desco M, Rosa A, Reig S, Gispert JD, Sanz J, Palomo T, Fananas L (2005) Ventricular enlargement in schizofrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene. Neuroimage 27:1002\u20131006","journal-title":"Neuroimage"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-006-1280-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00381-006-1280-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-006-1280-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:29:55Z","timestamp":1559057395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00381-006-1280-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,9]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1007\/s00381-006-1280-3","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,9]]}}}